Synthesis, cytotoxicity, and DNA-binding levels of ammine/cyclohexylamine platinum(II) complexes with dicarboxylates

Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry

Volumn 36, Issue 4, 2006, Pages 345-351

  Zhang, Jinchao ^a   Yong, Shen ^a  

^a HEBEI UNIVERSITY   (China)

Author keywords

Ammine cyclohexylamine platinum(II) complexes; Cell cycle; Cytotoxicity; DNA binding; Synthesis

Indexed keywords

EID: 33646509047     PISSN: 15533174     EISSN: 15533182     Source Type: Journal    
DOI: 10.1080/15533170600651462     Document Type: Article

References (27)

1. Sadler, P. J.; Guo, Z. J. Metal complexes in medicine: Design and mechanism of action. Pure & Appl. Chem. 1998, 70 (4), 863-871.
2. Wong, E.; Giandomenico, C. M. Current status of platinum-based antitumor drugs. Chem. Rev. 1999, 99, 2451-2466.
3. Ho, Y. P.; Au-Yeung, S. C. F.; Kenneth, K. W. T. Platinum-based anticancer agents: innovative design strategies and biological perspectives. Med. Res. Rev. 2003, 23 (5), 633-655.
4. Jakupec, M. A.; Galanski, M.; Keppler, B. K. Tumour-inhibiting platinum complexes-state of the art and future perspectives. Rev. Physiol. Biochem. Pharmacol. 2003, 146, 1-53.
5. Boulikas, T.; Vougiouka, M. Cisplatin and platinum drugs at the molecular level (review). Oncol. Rep. 2003, 10, 1663-1682.
6. Farrell, N. Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin. Cancer Invest. 1993, 11 (5), 578-589.
7. Hambley, T. W. The influence of structure on the activity and toxicity of Pt anti-cancer drugs. Coordin. Chem. Rev. 1997, 166, 181-223.
8. Yoshida, M.; Khokhar, A. R.; Siddik, Z. H. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(iv) complexes in tumor cells resistant to cis-diamminedichloroplatinum(Ii) or trans-1R,2R-1S,2S-) diaminocyclohexanetetrachloroplatinum(IV). Cancer Res. 1994, 54, 4691-4697.
9. Orr, R. M.; O'Neill, C. F.; Nicolson, M. C.; Barnard, C. F. J.; Murrer, B. A.; Giandomenico, C. M.; Vollano, J. F.; Harrap, K. R. Evaluation of novel ammine/amine platinum(IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Br. J. Cancer 1994, 70, 415-420.
10. Kelland, L. R.; Murrer, B. A.; Abel, G.; Giandomenico, C. M.; Mistry, P.; Harrap, K. R. Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res. 1992, 52 (4), 822-828.
11. Orr, R. M.; Barnard, C. F. J.; Murrer, B. A.; O'Neill, C. F.; Nicolson, M. C.; Balazova, E.; Harrap, K. R. Evaluation of novel platinum(II), and platinum(IV) ammine/amine complexes in L1210 murine leukemia cell lines sensitive and resistant to cisplatin and tetraplatin. Cell. Pharmacol. 1993, 1 (1), 17-23.
12. Zhang, J. C.; Gong, Y. Q.; Zheng, X. M. Synthesis, Characterization and antitumor activity of platinum(II) complexes of mixed ammine/amine with bidentate carboxylates. Synth. React. Inorg. Met-Org. Chem. 2002, 32, 49-57.
13. Khokhar, A. R.; Deng, Y.; Al-baker, S.; Yoshida, M.; Siddik, Z. H. Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes. J. Inorg. Biochem. 1999, 51, 677-687.
14. Rochon, F. D.; Kong, P. C. Iodo-bridged complexes of platinum(II) and synthesis of cis mixed-amine platinum(II) compounds. Can. J. Chem. 1986, 64, 1894-1896.
15. Mosmmann, L. M. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Immunol. Methods 1983, 65 (1-2), 55-63.
16. Ferlini, C.; Cesare, D. S.; Rainaldi, G.; Malorni, V.; Samoggia, P.; Biselli, R.; Fattorossi, A. Flow cytometric features of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 1996, 24 (2), 106-115.
17. Mellish, K. J.; Barnard, C. F.; Murrer, B. A.; Kelland, L. R. DNA-binding properties of novel cis- and trans-platinum-based anticancer agents in 2 human ovarian carcinoma cell lines. Int. J. Cancer 1995, 62 (6), 717-723.
18. Greary, W. J. The use of conductivity measurements in organic solvent for the characterization of coordination compounds. Coord. Chem. Rev. 1971, 7, 81-122.
19. Deacon, G. B.; Phillips, R. J. Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination. Coord. Chem. Rev. 1980, 33, 227-250.
20. Reedijk, J. New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA. Proc. Natl. Acad. Sci. USA 2003, 100 (7), 3611-3616.
21. Yang, Z.; Faustino, P. J.; Andrews, P. A.; Monastra, R.; Rasmussen, A. A.; Ellison, D.; Cullen, K. J. Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines. Cancer Chemother. Pharmacol. 2000, 46, 255-262.
22. Luo, X.; Budihardjo, I.; Zou, H.; Slaughter, C.; Wang, X. Bid, a Bcl2 interacting protein mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94, 481-490.
23. Mueller, T.; Voigt, W.; Simon, H.; Fruehauf, A.; Bulankin, A.; Grothey, A.; Schmoll, H.-J. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res. 2003, 63, 513-521.
24. Roberts, J. D.; Peroutka, J.; Farrell, N. Cellular pharmacology of polynuclear platinum anti-cancer agents. J. Inorg. Biochem. 1999, 77, 51-57.
25. Gourdier, I.; Grabbe, L.; Andreau, K.; Pau, B.; Kroemer, G. Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA. Oncogene 2004, 23 (45), 7449-7457.
26. Mandic, A.; Hansson, J.; Linder, S.; Shoshan, M. C. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J. Biol. Chem. 2003, 278 (11), 9100-9106.
27. Speelmans, G.; Sips, W. H. H. M.; Grisel, R. J. H.; Straffhorst, R. W. H. M.; Fichtinger-Schepman, A. M. J.; Reedijk, J.; De Kruijff, B. The interaction of the anticancer drug cisplatin with phospholipids is specific for negatively charged phospholipids and takes place at low chloride ion concentration. Biochim. Biophys. Acta. 1996, 1283, 60-66.